BSE filing, NSE: MINDSPACE. Summary written from the filing by ALFA Finder's alert engine.
Mindspace Business Parks REIT: key numbers
- Share price
- ₹482.99
- Market cap
- ₹29,423 Cr
- Revenue (annual)
- ₹3,216 Cr
- Net profit (annual)
- ₹651.9 Cr
- P/E (TTM)
- 38.9×Sector 34.0×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mindspace Business Parks REIT
All →Mindspace Business Parks REIT Results Update
Mindspace REIT reported Q1 FY27 financial results with NOI at INR 7,880 million and DPU at INR 6.67. The company also announced expansion plans for new office projects.
Mindspace Business Parks REIT Q1 FY27 Results: Net Profit ₹271.8 Cr, Up 62.9% YoY
Mindspace Business Parks REIT reported revenue from operations of ₹946.4 Cr (+27.8% YoY) and net profit of ₹271.8 Cr (+62.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹271.8 Cr · +62.9% YoY
Mindspace Business Parks REIT Debt & Borrowing: ₹600 Cr
Mindspace Business Parks REIT allotted 60,000 non-convertible debentures. The total principal amount aggregates to ₹600 Crore.
- Value
- ₹600.0 Cr
- Execution
- 2 years
Mindspace Business Parks REIT Annual General Meeting
Mindspace Business Parks REIT held its 6th Annual Meeting of unitholders on July 24, 2026. The meeting discussed the financial statements and reappointed statutory auditors.
Mindspace Business Parks REIT Board Meeting Date
Mindspace Business Parks REIT announced a board meeting for August 5, 2026. The meeting will consider financial results and distribution declarations for the June quarter.
Mindspace Business Parks REIT Credit Rating
ICRA reaffirmed Mindspace REIT's 'AAA/Stable' issuer rating. It also assigned 'AAA/Stable' to INR 510 Crore proposed NCDs and reaffirmed ratings for INR 11,490 Crore debt.
- Value
- ₹12,000 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.